These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10511603)

  • 1. Re: Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Huff J; Waalkes M; Nyska A; Chan P
    J Natl Cancer Inst; 1999 Oct; 91(19):1690-1. PubMed ID: 10511603
    [No Abstract]   [Full Text] [Related]  

  • 2. Arsenic trioxide.
    Wilkinson K
    Clin J Oncol Nurs; 2001; 5(5):237-8. PubMed ID: 11899773
    [No Abstract]   [Full Text] [Related]  

  • 3. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide.
    Litzow MR
    Expert Opin Pharmacother; 2008 Jul; 9(10):1773-85. PubMed ID: 18570609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia.
    Kizaki M; Muto A; Kinjo K; Ueno H; Ikeda Y
    J Natl Cancer Inst; 1998 Dec; 90(24):1906-7. PubMed ID: 9862629
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.
    Au WY; Lang BH; Fong BM; Mao KJ; Tam S
    Leuk Lymphoma; 2014 May; 55(5):1184-5. PubMed ID: 23964647
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinogenic risk of retained arsenic after successful treatment of acute promyelocytic leukemia with arsenic trioxide: a cause for concern?
    Firkin F
    Leuk Lymphoma; 2014 May; 55(5):977-8. PubMed ID: 24144311
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular targets of arsenic trioxide in malignant cells.
    Miller WH
    Oncologist; 2002; 7 Suppl 1():14-9. PubMed ID: 11961205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia.
    Barbey JT; Soignet S
    Ann Intern Med; 2001 Nov; 135(9):842-3. PubMed ID: 11694116
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arsenic trioxide in the treatment of acute promyelocytic leukaemia].
    Ercilla Liceaga M; Andueza Granados K; Fernández González I; Barcia Romero MJ
    Farm Hosp; 2003; 27(2):93-100. PubMed ID: 12717564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological and clinical properties of arsenic trioxide (Trisenox) for relapse or refractory acute promyelocytic leukemia therapy].
    Tajima M
    Nihon Yakurigaku Zasshi; 2005 Jun; 125(6):389-96. PubMed ID: 16079563
    [No Abstract]   [Full Text] [Related]  

  • 13. Does arsenic trioxide impact fertility?
    Stein EM; Tallman MS
    Leuk Lymphoma; 2012 Nov; 53(11):2099-100. PubMed ID: 22524541
    [No Abstract]   [Full Text] [Related]  

  • 14. Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy.
    Huan SY; Yang CH; Chen YC
    Leuk Lymphoma; 2000 Jul; 38(3-4):283-93. PubMed ID: 10830735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide for the treatment of acute promyelocytic leukemia.
    Lam MS; Ignoffo RJ
    Cancer Pract; 2001; 9(3):155-7. PubMed ID: 11879303
    [No Abstract]   [Full Text] [Related]  

  • 16. Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.
    Rojewski MT; Körper S; Schrezenmeier H
    Leuk Lymphoma; 2004 Dec; 45(12):2387-401. PubMed ID: 15621751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide.
    Galm O; Fabry U; Osieka R
    Leukemia; 2000 Feb; 14(2):343-4. PubMed ID: 10673758
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of acute promyelocytic leukemia with arsenic trioxide.
    Tamm I; Paternostro G; Zapata JM
    N Engl J Med; 1999 Apr; 340(13):1043; author reply 1044-5. PubMed ID: 10189285
    [No Abstract]   [Full Text] [Related]  

  • 19. Complete atrioventricular block after arsenic trioxide treatment in an acute promyelocytic leukemic patient.
    Huang CH; Chen WJ; Wu CC; Chen YC; Lee YT
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):965-7. PubMed ID: 10392399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenthood in patients with acute promyelocytic leukemia after treatment with arsenic trioxide: a case series.
    Gupta S; Bagel B; Gujral S; Subramanian PG; Khattry N; Menon H; Nair R
    Leuk Lymphoma; 2012 Nov; 53(11):2192-4. PubMed ID: 22452590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.